Skip to main content

Saphris 10 mg (asenapine) sublingual tablets, 6x10 count blister packs, Rx only, Black Cherry Flavor, Manufactured by: Catalent UK Swindon, Zydis Ltd, Blagrove, Swindon, Wilshire SN5 BRU, UK Distributed by Forest Pharmaceuticals, Inc. subsidiary of Forest Laboratories, LLC, Cincinnati OH 45209 USA --- NDC 0456-2410-60; Shellpack containing 1 blister card --- NDC 0456-2410-06

Drug Recall

Official source record

Recall number
D-0880-2017
Event ID
77315
Classification
Class II
Status
Terminated
Recalling company
Forest Laboratories, LLC
Reason for recall
Labeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tablets
Report date
June 7, 2017
Recall initiation date
May 18, 2017
Termination date
November 15, 2018
Distribution pattern
Nationwide

Drug product identifiers

Manufacturer
Allergan, Inc.
Brand name
SAPHRIS
Generic name
ASENAPINE MALEATE
Substance name
ASENAPINE MALEATE
Product NDCs
0456-2402; 0456-2405; 0456-2410
Package NDCs
0456-2402-06; 0456-2402-10; 0456-2402-11; 0456-2402-60; 0456-2402-63; 0456-2405-06; 0456-2405-10; 0456-2405-11; 0456-2405-60; 0456-2405-63; 0456-2410-06; 0456-2410-10; 0456-2410-11; 0456-2410-60; 0456-2410-63
Route
SUBLINGUAL

Where this information comes from

View FDA enforcement record -- the specific openFDA drug enforcement record this summary was built from.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for details.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to the FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this medication?

Do not start, stop, or change any medication based on this page. Follow the instructions published by the FDA and the recalling company (see the source links below), and talk to your pharmacist or physician if you have questions about a specific medication.

Where can I find more official information?

The source links below, published by the FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

Public Health Trace republishes official FDA drug recall information -- it is not affiliated with the FDA, does not verify or supplement what the source has published, and does not provide medical advice. Never start, stop, or change a medication based on this page. Always follow the guidance of your pharmacist or physician, and consult the official source links above for the most current information. Read the full medical disclaimer.